Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast in Acute Bronchiolitis
NCT07770464Phase 2Recruiting
- Sponsor
- Pakistan Institute of Medical Sciences
- Start
- Jan 2026
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 2, randomised trial of montelukast in acute bronchiolitis (2 arms), sponsored by Pakistan Institute of Medical Sciences. Primary endpoint: Change in Clinical Severity Score at 72 hours. Started Jan 2026; status: recruiting.
02
Drugs
montelukast
03
Conditions
acute bronchiolitis
Beyond the preview
Go deeper on NCT07770464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07770464.